Pharma Stocks
-
Mankind Pharma Ltd Hits Intraday High with 5.29% Surge on…
Intraday Trading Highlights On the trading day, Mankind Pharma Ltd’s shares advanced by 5.29%, closing near the day’s peak price.…
Read More » -
Natco Pharma shares surge over 11% in four sessions, here is why
Upstox Securities Pvt. Ltd.: SEBI Registration No. INZ000315837 | NSE TM Code: 13942 | BSE TM Code: 6155 | CDSL…
Read More » -
Tarsus Pharmaceuticals (TARS) Narrowing EPS Loss Backs Bullish Earnings Turnaround Narrative
Tarsus Pharmaceuticals (TARS) closed FY 2025 with fourth quarter revenue of US$151.7 million and a basic EPS loss of US$0.20,…
Read More » -
Univar Solutions to distribute Ingredion pharma starches
Pharmaceutical manufacturers will benefit from deep expertise and an extensive distribution network paired with Ingredion’s functional excipients DOWNERS GROVE, Ill.,…
Read More » -
Natco Pharma, Eris Lifesciences shares jump up to 6% on partnership for Semaglutide launch in India
Shares of Natco Pharma and Eris Lifesciences jumped in trade on Tuesday after the companies announced a strategic partnership for…
Read More » -
A Look At InnoCare Pharma (SEHK:9969) Valuation As Dermatology Trials For Soficitinib Progress
InnoCare Pharma (SEHK:9969) has drawn fresh investor attention after dosing the first patient in a Phase II/III trial of TYK2…
Read More » -
Separation Overhang Continues to Weigh on Bausch Health Companies Inc. (BHC) Outlook
Bausch Health Companies Inc. (NYSE:BHC) is among the 7 Oversold Pharma Stocks to Buy Now. Separation Overhang Continues to Weigh…
Read More » -
Should You Buy ANI Pharmaceuticals Stock Before Q4 Earnings? – February 23, 2026
Key Takeaways ANI Pharmaceuticals reports Q4 2025 earnings Feb. 27, with sales seen at $233M and EPS at $1.99. ANIP’s…
Read More » -
Anuh Pharma Ltd Technical Momentum Shifts Amid Bearish Si…
Technical Trend Overview Recent analysis reveals that Anuh Pharma’s technical trend has deteriorated from mildly bearish to outright bearish. The…
Read More » -
How Positive CAH Phase 2 Data And Palsonify Uptake At Crinetics Pharmaceuticals (CRNX) Has Changed Its Investment Story
Recently, Crinetics Pharmaceuticals reported encouraging Phase 2 data in congenital adrenal hyperplasia, showing that a meaningful share of patients in…
Read More »